Targeted therapies: J-ALEX hints at new first-line in NSCLC.

Targeted therapies: J-ALEX hints at new first-line in NSCLC.

Nat Rev Clin Oncol. 2017 May 31;:

Authors: Hutchinson L

PMID: 28561073 [PubMed - as supplied by publisher]

http://ift.tt/2sr44fl